Minor papilla approach improves technical success of nasopancreatic drainage-based pancreatic juice cytology for early pancreatic cancer diagnosis

Abstract

Background and study aims

Early detection of pancreatic cancer (PC) is vital for improving survival, yet it often relies on indirect imaging findings rather than detection of distinct masses. Recently, pancreatic juice cytology obtained via nasopancreatic drainage (NPD-PJC) has emerged as a valuable diagnostic approach for early-stage disease. However, technical challenges associated with NPD placement remain a significant limitation. This study aimed to assess whether incorporating a minor papilla approach improves the technical success rate for NPD-PJC in patients with suspected early-stage PC.

Patients and methods

We conducted a retrospective study of patients scheduled for NPD placement for NPD-PJC between January 2015 and November 2024. Demographic and procedural data were collected, including endoscopic retrograde pancreatography (ERP) findings and outcomes associated with major and minor papilla approaches. Potential risk factors for technical failure and post-ERP pancreatitis (PEP) were evaluated.

Results

A total of 81 cases were planned for NPD-PJC within the study period to differentiate early-stage PC. The success rate of the major papilla approach alone was 81.5%, which significantly increased to 93.8% (P = 0.00157) with the addition of the minor papilla approach. Abnormal ductal configurations were associated with failure of the conventional approach (odds ratio 23.4). The minor papilla approach was not a significant risk factor for PEP, whereas younger age (≤ 70 years) and high body mass index (≥ 25) were identified as PEP risk factors.

Conclusions

Incorporating the minor papilla approach substantially improves technical success of NPD-PJC without increasing PEP risk, underscoring the importance of individualized ERP strategies for early-stage PC diagnosis.

Keywords

Pancreatobiliary (ERCP/PTCD) - Diagnostic ERC - ERC topics - Quality and logistical aspects - Performance and complications

Publikationsverlauf

Eingereicht: 17. März 2025

Angenommen nach Revision: 05. Juni 2025

Accepted Manuscript online:
10. Juni 2025

Artikel online veröffentlicht:
23. Juli 2025

• References

• 1 Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol 2019; 10: 10-27
• 2 Arnold M, Abnet CC, Neale RE. et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020; 159: 335-349.e15
• 3 Egawa S, Toma H, Ohigashi H. et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 2012; 41: 985-992
• 4 Kikuyama M, Kamisawa T, Kuruma S. et al. Early diagnosis to improve the poor prognosis of pancreatic cancer. Cancers 2018; 10: 48
• 5 Brierley JD, Gospodarowicz MK, Wittekind C. Union for International Cancer Control. TNM classification of malignant tumours. eighth edition. Hoboken, New Jersey, USA: JOHN WILEY & SONS, LTD; 2017.
• 6 Kanno A, Masamune A, Hanada K. et al. Multicenter study of early pancreatic cancer in Japan. Pancreatology 2018; 18: 61-67
• 7 Satoh T, Kikuyama M, Kawaguchi S. et al. Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE). Clin J Gastroenterol 2017; 10: 541-545
• 8 Nakahodo J, Kikuyama M, Nojiri S. et al. Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ. Pancreatology 2020; 20: 1689-1697
• 9 Nakahodo J, Kikuyama M, Fukumura Y. et al. Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. Pancreatology 2022; 22: 1148-1158
• 10 Sagami R, Yamao K, Nakahodo J. et al. Pre-operative imaging and pathological diagnosis of localized high-grade pancreatic intra-epithelial neoplasia without invasive carcinoma. Cancers 2021; 13: 945
• 11 Yamao K, Takenaka M, Ishikawa R. et al. Partial pancreatic parenchymal atrophy is a new specific finding to diagnose small pancreatic cancer (≤10 mm) Including carcinoma in situ: Comparison with localized benign main pancreatic duct stenosis patients. Diagnostics (Basel) 2020; 10: 445
• 12 Tanaka S, Nakao M, Ioka T. et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology 2010; 254: 965-972
• 13 Yoon SH, Lee JM, Cho JY. et al. Small (≤20 mm) Pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 2011; 259: 442-452
• 14 Kaneko J, Ishiwatari H, Sasaki K. et al. Macroscopic visible core length can predict the histological sample quantity in endoscopic ultrasound-guided tissue acquisition: Multicenter prospective study. Dig Endosc 2022; 34: 622-631
• 15 Ishiwatari H, Sato J, Fujie S. et al. Gross visual inspection by endosonographers during endoscopic ultrasound-guided fine needle aspiration. Pancreatology 2019; 19: 191-195
• 16 Hanada K, Shimizu A, Kurihara K. et al. Endoscopic approach in the diagnosis of high-grade pancreatic intraepithelial neoplasia. Dig Endosc 2022; 34: 927-937
• 17 Nakamura S, Ishii Y, Serikawa M. et al. Diagnostic ability and safety of repeated pancreatic juice cytology using an endoscopic nasopancreatic drainage catheter for pancreatic ductal adenocarcinoma: A multicenter prospective study. Diagnostics (Basel) 2023; 13: 2696
• 18 Iiboshi T, Hanada K, Fukuda T. et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas 2012; 41: 523-529
• 19 Satoh T, Kawaguchi S, Takeda S. et al. Comparison of diagnostic yield and safety of serial pancreatic juice aspiration cytologic examination (SPACE) with different indications. Diagnostics (Basel) 2023; 13: 1498
• 20 Sagami R, Mizukami K, Nishikiori H. et al. Pancreatic juice cytology for diagnosing invasive pancreatic carcinoma/high-grade pancreatic intraepithelial neoplasia without visible tumors on endoscopic ultrasound. Pancreatology 2024; 24: 740-746
• 21 Satoh T, Kaneko J, Nakatani E. et al. Repeated pancreatic juice cytology via endoscopic nasopancreatic drainage catheter combined with clinical findings improves diagnostic ability for malignant cases of suspected pancreatic cancer with non-identifiable tumors. Pancreatology 2025; 25: 125-133
• 22 Sagami R, Nakahodo J, Minami R. et al. True diagnostic ability of EUS-guided fine-needle aspiration/biopsy sampling for small pancreatic lesions ≤10 mm and salvage diagnosis by pancreatic juice cytology: a multicenter study. Gastrointest Endosc 2024; 99: 73-80
• 23 Gonoi W, Akai H, Hagiwara K. et al. Meandering main pancreatic duct as a relevant factor to the onset of idiopathic recurrent acute pancreatitis. PLoS One 2012; 7: e37652
• 24 Brown NG, Howell DA, Brauer BC. et al. Minor papilla endotherapy in patients with ventral duct obstruction: identification and management. Gastrointest Endosc 2017; 85: 365-370
• 25 Nakazawa T, Hayashi K, Naitoh I. et al. Endoscopic approach via the minor papilla for the treatment of pancreatic stones. Clin Endosc 2012; 45: 189-193
• 26 Satoh T, Kawaguchi S, Kanemoto H. et al. Pancreatic carcinoma in situ with focal pancreatic parenchymal atrophy diagnosis using serial pancreatic juice aspiration cytological examination via the minor papilla. Endoscopy 2025; 57: E386-E387
• 27 White JJ, Roberts ZN, Gest TR. et al. Pancreas divisum: a common developmental variant that deserves attention in preclinical medical education: Pancreas divisum in preclinical medical teaching. Clin Anat 2014; 27: 1038-1045
• 28 Kamisawa T, Tu Y, Egawa N. et al. Clinical implications of incomplete pancreas divisum. JOP 2006; 7: 625-630
• 29 Kanno Y, Koshita S, Ogawa T. et al. Predictive value of localized stenosis of the main pancreatic duct for early detection of pancreatic cancer. Clin Endosc 2019; 52: 588-597
• 30 Cotton PB, Garrow DA, Gallagher J. et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-88
• 31 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
• 32 Song MH, Kim M-H, Lee SK. et al. Endoscopic minor papilla interventions in patients without pancreas divisum. Gastrointest Endosc 2004; 59: 901-905
• 33 Williams EJ, Taylor S, Fairclough P. et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39: 793-801
• 34 Beran A, Aboursheid T, Ali AH. et al. Predictors of post-endoscopic retrograde cholangiopancreatography pancreatitis: A comprehensive systematic review and meta-analysis. Clin Gastroenterol Hepatol 2024; 16 Online ahead of print
• 35 Fujisawa T, Kagawa K, Hisatomi K. et al. Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol 2016; 51: 931-938